|
|
| | Methyl (R)-5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate Basic information |
| Product Name: | Methyl (R)-5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate | | Synonyms: | Methyl (R)-5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate;Methyl 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]benzoate;Salmeterol Impurity 2;Methyl 5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate;Methyl (R)-2-(benzyloxy)-5-(2-bromo-1-hydroxyethyl)benzoate;Benzoic acid, 5-[(1R)-2-bromo-1-hydroxyethyl]-2-(phenylmethoxy)-, methyl ester | | CAS: | 160889-18-9 | | MF: | C17H17BrO4 | | MW: | 365.22 | | EINECS: | | | Product Categories: | | | Mol File: | 160889-18-9.mol |  |
| | Methyl (R)-5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate Chemical Properties |
| Boiling point | 496.4±45.0 °C(Predicted) | | density | 1.425±0.06 g/cm3(Predicted) | | pka | 12.85±0.20(Predicted) |
| | Methyl (R)-5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate Usage And Synthesis |
| Uses | Methyl (R)-5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate is used in the preparation of phenylpyrazinoylguanidines as sodium channel blockers possessing β-agonist activity. These compounds are useful for promoting hydration of mucosal surfaces and treating a variety of disease conditions. |
| | Methyl (R)-5-(2-bromo-1-hydroxyethyl)-2-(phenylmethoxy)benzoate Preparation Products And Raw materials |
|